WHEN STRINGENCY EQUATES SAFETY
The Source: European State-certified Closed-colony of Sheep** & Rabbits raised for more than 40 Generations.
The cellular extracts used as MF3s product ingredients are specially procured from a European State-certified closed-colony* of sheep** bred specifically for medical purposes. Starkly different from the practice of commercial animal breeding, every batch of animals in the closed colony is raised for at least 40 generations since 1973, surpassing the requirements of global regulatory bodies such as WHO and USA-FDA.
The closed colony of animals is bred under controlled dietetic conditions supervised by an experienced team of veterinarians. The European Federal Authorities maintain records of all births, deaths, movements and medical data of these medical animals, as well as the Identification Ear Marks of each specific animal concerned.
*Closed-colony breeding refers to the practice of growing an animal population in a sealed and marginalized environment, which prevents contact with organisms outside the protected breeding region and limits the exposure to foreign sources of disease and contamination.
**Sheep placenta in the PE softgel is available in selected territories only; and where applicable is declared as selected nutrients on product labelling.
WHY SAFETY MATTERS
Closed-colony breeding of at least 25 to 30 generations is currently one of the safest production standards imposed for any form of cellular therapy. It eliminates risky genetic lineage of the procured animals, and adds accountability for consumers (knowing that every generation of animals are tagged upon birth, and every medical data or any form of aberration are recorded).
Nowadays, many reckless manufacturing and handling procedures – ‘procuring raw cellular materials ‘from the slaughterhouse’, ‘mass piling into freezer for days’, and ‘randomly selecting raw material blocks for processing’ – are exposing consumers to the risk of zoonosis transmission.
Therefore, adopting a stringently assessed and systemized procedure to procure raw cellular materials from pathologically safe animals is important and necessary. And this is the core production values that MF3 has upheld since 1991.